Piper Sandler Maintains Cytek Biosciences(CTKB.US) With Buy Rating, Cuts Target Price to $8.25

Futu NewsNov 25 20:30 · Ratings

In the Wake of Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Latest US$84m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions

Simply Wall StNov 22 00:13

Cytek Biosciences to Participate in the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswireNov 21 05:05

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaNov 20 05:05

Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Maintains Target Price $9

Futu NewsNov 19 16:36 · Ratings

Cautious Hold on Cytek Biosciences Amid Recovery and Growth Opportunities

TipRanksNov 19 09:47 · Ratings